Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001415889-24-021234

Options or other derivatives

  • Chief Strategy Officer acquired 110,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Turner Bruce Chief Strategy Officer 2024-08-09 Grant or award · Stock option (right to buy) +110,000 110,000 D
Loading xslF345X05/form4-08132024_090830.xml…